Thursday 23 May 2013
'premium' content
Register
|
Forgot password?
|
AusPharmList
|
Advertisers
and Sponsors
LOGIN (email address)
PASSWORD
Remember me:
Register
Forgot password?
Edit my member profile
Renew my premium subscription
Free trial
SEARCH SITE:
Pharmacy News
In The News
Opinion
Editorial
Continuing Education
Research Roundup
Practice Pearls
Polls
Photo Of The Week
Joke Of The Week
The Last Word
CHECK YOUR EMAIL:
HOME
FIND A JOB
PHARMACY NEWS
IN THE NEWS
OPINION
EDITORIAL
CONTINUING EDUCATION
PHARMACY APPS
RESEARCH ROUNDUP
PRACTICE PEARLS
POLLS
PHOTO OF THE WEEK
JOKE OF THE WEEK
STUDENT RESOURCES
THE LAST WORD
ABOUT AUSPHARM
CONTACT US
ADVERTISING
AusPharm
Online poll
22/05/2013 : Low dose codeine containing analgesics (S3) should:
remain in S3, pharmacists manage the issues well
remain in S3, but gee it`s hard separating the misusers from the genuine users
remain in S3, but I need further training to handle requests for these products
return to S2 for small packs, large packs S3
be removed from the market altogether - there`s no evidence they work
be up-scheduled into S4
[
View Results
]
Show previous results
Login
You are not logged in - please use the login box to log in